Latest News

 Filter by Provider

Production climbs as the company nears positive free cash flow in 2027.

Reinsurance premiums climbed sharply while persistency stayed elevated.

Record nine-month results and a 2030 growth target already in hand.

It missed badly on third-quarter net income.

Sun Life Financial (TSX:SLF) might be a massive bargain after Thursday's vicious plunge as stock markets sold off hard.

Enbridge’s current dividend needs roughly $42,600 in shares to average $200 monthly, with payments arriving every quarter.

Record NAV and new SBIC capacity marked a steady quarter for the lender.

Acquisition pipeline and Arkansas sale set up the next growth phase.

Insurance income more than doubled as Mount Logan reshaped its fee base.

Aurora-Idaho enters steel installation as fuel and isotope plans advance.

Eli Lilly could thrive even as competition in the weight-loss market intensifies.

A record quarter of investments and a new U.K. expansion drove results.

Management outlines its path back to breakeven as legacy loan resolutions continue.

Management raised 2026 guidance and sees stronger group bookings ahead.

Data center demand lifts capital plan to $25 billion and a higher growth target.

Data center demand is reshaping the utility's growth plans and capital spending outlook.

Delivery volume tripled, yet one platform partner's decline is a point management flagged.

Zai Lab (NASDAQ:ZLAB) reported $108.2 million in third-quarter revenue and said it expects to return to year-over-year product revenue growth in 2027, while advancing its lead cancer drug candidate toward potential U.S. regulatory submissions next year. Founder, CEO and Chairperson Samantha Du said

Air Products and Chemicals (NYSE:APD) forecast adjusted earnings growth of 5% to 8% in fiscal 2027, as the industrial gases company shifts spending toward its core business and works to complete legacy energy transition projects. The outlook followed a fiscal 2026 in which sales rose 8% and adjuste

Eikon Therapeutics (NASDAQ:EIKN) expects an interim analysis of its lead melanoma study in the first half of 2027 and estimates that definitive data from that trial and a lung cancer study could be available around the middle of 2029, CEO Roger Perlmutter said during a JPMorgan biotech call. Both s

Verastem (NASDAQ:VSTM) reported $24 million in third-quarter 2026 net product revenue as refills of its ovarian cancer treatment offset a moderation in new patient starts. The company also outlined plans to begin a late-stage pancreatic cancer trial for its experimental drug VS-7375 by year-end. Re

Alpha Metallurgical Resources (NYSE:AMR) reported higher third-quarter shipments and adjusted earnings, while laying out a 2027 shipping plan that accounts for prolonged repairs at a key export terminal. The metallurgical coal producer shipped 3.9 million tons in the third quarter of 2026, up from

Artivion (NYSE:AORT) reported 9% constant-currency revenue growth in the third quarter of 2026, while adjusted earnings declined as the medical device maker invested in manufacturing and prepared for the U.S. launch of its NEXUS aortic repair system. Revenue rose to $123.8 million, with growth led

Viemed Healthcare (NASDAQ:VMD) reported record third-quarter revenue and higher earnings, as growth in sleep therapy and equipment sales helped the home healthcare provider raise the lower end of its full-year revenue outlook. Revenue rose 12.2% from a year earlier to $80.7 million, while net incom

Verisk Analytics (NASDAQ:VRSK) reported higher third-quarter revenue and adjusted earnings per share as subscription growth and stronger-than-expected transactional revenue helped offset pressure from lighter weather activity and softer property insurance markets. The company maintained its full-ye

Viasat (NASDAQ:VSAT) reported fiscal second-quarter revenue growth driven by its defense business, but said commercial aviation revenue is expected to decline in fiscal 2028 as customer announcements affect part of its business over time. The satellite communications company also said it now expect

VSE (NASDAQ:VSEC) raised its 2026 revenue growth and profitability outlook after reporting record third-quarter results, driven by demand for aircraft engine repairs, acquisition contributions and margin gains in its core aviation business. Revenue rose 91% year over year to $541 million, including

Fee income and niche lines grew as property and energy pullbacks offset gains.

Eagle Ford sale and raised synergy targets shape the quarter's outlook.

The cloud giant maxed out its new four-year fundraising cap in five days. What did it cost shareholders?

Build toward $1,000 a month in tax-free income with a TFSA. See how Enbridge, Scotiabank and ZWC could help, and how much you would need.

LiDAR now drives a fifth of sales in Senstar's record quarter.

Arbex lifts revenue, but rising energy and logistics costs weigh on margins.

Pancreatic data and a planned Phase III launch highlighted the call.

Revenue surged as the company shifted from testing to paid contracts.

Record backlog and raised guidance sit alongside a seasonal cash squeeze.

Libby complex commissioning and a $220 million equity raise defined the quarter.

Traffic pressure drove a sales drop, but profit beat management's outlook.

Record output and a fleet deal reshape its costs ahead of 2027.

Two divestitures and record receivables shape a strong quarter.

Premium growth accelerated, yet management flagged a looming margin headwind.

Utility boosts its capital plan as data center demand pipeline keeps growing.

Margins narrowed as acquisition spending rose, while the qualified pipeline grew sharply.

Stocks are tumbling post-election, but Warren Buffett has some reassuring advice.

Management outlined a smaller 2028 prototype and a shift toward debt reduction

Ziff Davis (NASDAQ:ZD) reported lower third-quarter revenue and adjusted earnings as declining Google search referrals and weaker advertising weighed on its businesses, though executives said results were broadly in line with their expectations. Revenue from continuing operations fell to $289.3 mil

Bowlero (NYSE:BOWL), which held its earnings call under the name Lucky Strike Entertainment, reported fiscal first-quarter revenue growth of 3.5% and said it would suspend its quarterly dividend as it seeks to reduce debt. Revenue for the quarter ended Sept. 27 rose to $302.6 million, while adjuste

Bob's Discount Furniture (NYSE:BOBS) reported higher third-quarter sales and adjusted profit as customers bought more premium furniture and new stores contributed to growth, but the retailer lowered its full-year gross margin outlook because of rising fuel costs. Net revenue rose 10.3% to $680 mill

AMN Healthcare Services (NYSE:AMN) reported higher third-quarter revenue as demand for travel nurses and allied healthcare professionals grew, while a favorable adjustment tied to past labor disruptions also boosted results. Revenue rose 13% year over year to $717 million, or 6% excluding labor dis

American Homes 4 Rent (NYSE:AMH) raised its 2026 earnings outlook after reporting third-quarter growth in rental revenue and receiving property tax assessments that came in below its expectations in several states. The single-family rental company increased the midpoint of its full-year core funds